161178-24-1 Usage
Uses
Used in Pharmaceutical Industry:
1H-Inden-4-ol,7-fluoro-2,3-dihydro-(9CI) is used as a building block for the synthesis of pharmaceutical drugs due to its unique structure and properties. It contributes to the development of new drug candidates for various therapeutic areas.
Used in Chemical Industry:
In the chemical industry, 1H-Inden-4-ol,7-fluoro-2,3-dihydro-(9CI) serves as a key intermediate for the production of agrochemicals and other fine chemicals. Its versatility allows for the creation of a range of chemical products.
Used in Material Science:
1H-Inden-4-ol,7-fluoro-2,3-dihydro-(9CI) is utilized in material science for its potential applications in the development of advanced materials, taking advantage of its chemical and physical properties.
Used in Advanced Technologies:
1H-Inden-4-ol,7-fluoro-2,3-dihydro-(9CI) also holds promise for use in advanced technologies, where its specific characteristics can be leveraged to enhance or create innovative solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 161178-24-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,1,7 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 161178-24:
(8*1)+(7*6)+(6*1)+(5*1)+(4*7)+(3*8)+(2*2)+(1*4)=121
121 % 10 = 1
So 161178-24-1 is a valid CAS Registry Number.
161178-24-1Relevant articles and documents
6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
-
Paragraph 0145-0146; 0289; 0292, (2021/11/14)
A 6-oxo-1,6-dihydropyridazine derivative, a preparation method therefor and medical use thereof, in particular, a 6-oxo-1,6-dihydropyridazine derivative represented by general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivative, and use thereof as a NaV inhibitor and use thereof in the preparation of a drug for the treatment and/or prevention of pain and pain-related diseases. Each substituent in general formula (I) is the same as defined in the description.
